Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Takeda Pharmaceutical (TKPHF) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Takeda Pharmaceutical (TKPHF) over the last 8 years, with Q4 2025 value amounting to 0.48.

  • Takeda Pharmaceutical's Asset Utilization Ratio rose 442.61% to 0.48 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.48, marking a year-over-year increase of 442.61%. This contributed to the annual value of 0.3 for FY2025, which is 674.83% up from last year.
  • According to the latest figures from Q4 2025, Takeda Pharmaceutical's Asset Utilization Ratio is 0.48, which was up 442.61% from 0.48 recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Asset Utilization Ratio ranged from a high of 0.49 in Q2 2025 and a low of 0.25 during Q1 2021
  • For the 5-year period, Takeda Pharmaceutical's Asset Utilization Ratio averaged around 0.34, with its median value being 0.3 (2023).
  • In the last 5 years, Takeda Pharmaceutical's Asset Utilization Ratio surged by 10628444.83% in 2021 and then plummeted by 158.02% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Asset Utilization Ratio (Quarter) stood at 0.28 in 2021, then rose by 9.91% to 0.31 in 2022, then decreased by 0.21% to 0.31 in 2023, then skyrocketed by 50.38% to 0.46 in 2024, then increased by 4.43% to 0.48 in 2025.
  • Its Asset Utilization Ratio was 0.48 in Q4 2025, compared to 0.48 in Q3 2025 and 0.49 in Q2 2025.